Overview

A Clinical Trial to Evaluate Drug-drug Interactions and Safety Between "BR1015-1" and "BR1015-2" in Healthy Volunteers

Status:
Enrolling by invitation

Trial end date:
2021-10-22

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate pharmacokinetic interactions (Drug-Drug interaction) and safety between "BR1015-1" and "BR1015-2" in healthy volunteers.

Phase:

Phase 1

Details

Lead Sponsor:

Boryung Pharmaceutical Co., Ltd

Treatments:

Indapamide